Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Radient Pharmaceuticals has expanded its Onko-Sure cancer test distribution agreement with UniPharma Taiwan.
Subscribe to our email newsletter
As per the previous agreement, UniPharma had the exclusive right to distribute Radient’s cancer test in Taiwan.
The expanded distribution agreement includes Singapore, Hong Kong and Macau.
As a full-service distribution partner, UniPharma handles regulatory approvals in assigned territories.
Onko-Sure is a non-invasive in vitro diagnostic blood biomarker test for cancer.
UniPharma general manager Terry Lin said the company has increased its medical sales team and committed to present at upcoming regional cancer conferences to increase awareness of Onko-Sure.